A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM

NCT00980187 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Type 2 Diabetes Mellitus

Interventions

DRUG: Hydrochlorothiazide
DRUG: Indapamide

Sponsor

LaborMed Pharma S.A.